Kambo is a unique secretion offering a complex biochemical profile that remains unparalleled in the realm of natural medicines.


The bioactive 'peptides' that are found in Kambô bind with receptor sites found in the brain. These peptides perform hormone-like tasks while others provide support to vital cellular processes, acting as a key to the lock of our many biological syst…

The bioactive 'peptides' that are found in Kambô bind with receptor sites found in the brain. These peptides perform hormone-like tasks while others provide support to vital cellular processes, acting as a key to the lock of our many biological systems.

Chemical Cocktail

It is said that Scientist and Nobel Peace Prize nominee Vittorio Erspamer from the University of Rome described the Kambo secretion as a “fantastic chemical cocktail with potential medical applications, unequaled by any other amphibian.” Among the several dozen peptides identified in Kambo, Erspamer notes that up to 9% are bioactive.

These peptides have been shown to exert potent effects on various physiological systems, including:

  • Pain Relief: Certain peptides modulate pain responses, making Kambo potentially beneficial for chronic pain management.

  • Inflammation Reduction: The secretion helps mitigate inflammatory responses, aiding in conditions like arthritis.

  • Gastrointestinal Function: It stimulates gastric and pancreatic secretions and impacts smooth muscle activity, which can enhance digestive health.

  • Hormonal Regulation: Kambo peptides influence the adrenal cortex and pituitary gland, contributing to better stress management and hormonal balance.

Erspamer and colleagues categorized the Phyllomedusa skin peptides into three primary groups based on their activities: antimicrobial peptides (AMPs), smooth muscle-active peptides, and nervous system-active peptides.

Antimicrobial Potential

The timing of Kambo's emergence as a holistic remedy is significant, particularly given its potential to support the body in clearing viruses, bacteria, and other pathogens. Numerous research papers have documented the antimicrobial properties of peptides derived from Phyllomedusa frogs, highlighting their ability to combat infections effectively.

Medical Applications and Research

For the record, Kambo Care is not making medical claims.

Ongoing research is exploring the efficacy of Kambo peptides in treating a variety of health conditions, including:

Health Conditions Addressed

Infectious Diseases

  • HIV/AIDS

  • STDs

  • Herpes

Neurological Disorders

  • Alzheimer’s Disease

  • Parkinson’s Disease

  • Depression and Anxiety

Autoimmune and Endocrine Disorders

  • Autoimmune Diseases

  • Endocrine Disorders

Chronic Conditions

  • Chronic Pain Relief

  • Chronic Fatigue

  • Digestive Issues

Skin and Sensory Disorders

  • Skin and Eye Disorders

Reproductive Health

  • Infertility

Vascular and Circulatory Issues

  • Vascular Insufficiency

  • Circulation Issues

Organ Health

  • Organ Diseases

Infections

  • Candida, Mold, and Fungal Infections

Other Health Concerns

  • Cancer

  • Sports Medicine

  • Migraines

As research continues to unfold, Kambo's rich biochemical profile holds the promise of becoming a transformative agent in both traditional and modern healing practices.

In some cases there are contraindications for people on the above list.

 
Deltorphin I

KAMBO PEPTIDES

 

The main families of bioactive peptides identified in the Kambô secretion so far include:

Phyllomedusin – such as tachykinins (which also act as neuropeptides) – produce contraction at the smooth muscle level and increase secretions of the entire gastrointestinal tract such as the salivary glands, stomach, small and large intestine, pancreas and gallbladder. These are the main parts responsible for the deep purge produced by the administration of Kambô.

Phyllokinin and Phyllomedusins – both are potent vasodilators, increasing the permeability of the blood-brain barrier both for their own access as well as for that of other active peptides. Within this family are the medusins, which also have antimicrobial and antifungal properties.

Caeruleins and Sauvagines – They are peptides with chains of 40 amino acids with myotropic properties on the smooth muscles, producing a contraction of the colon and urinary bladder. They produce a drop in blood pressure accompanied by tachycardia. They stimulate the adrenal cortex and pituitary gland, contributing to greater sensory perception and increased resistance. Both peptides possess a great analgesic power, contributing to the increase of physical strength, the capacity to confront physical pain, stress, disease and diminish the symptoms of fatigue. In the medical field this family of peptides contributes to improved digestion and has analgesic properties against pain in renal colic, pain due to peripheral vascular insufficiency and tumour pain.

Dermorphin and deltorphin – These are small peptides composed of 7 amino acids. They are selective agonists of the opiate delta receptors, 4000 times more potent than morphine and 40 times more than the endogenous endorphins.

Ceruleins – Stimulate gastric, bile and pancreatic secretions, and certain smooth muscle. They could be used in the paralytic ileus and as a diagnostic medium in pancreatic dysfunction.

Tryptophilins – are neuropeptides consisting of 4 to 14 amino acids, which are opening up new perspectives on how the human brain works.

Adenoregulins – discovered in the 90s by John Daly’s team at the National Institute of Health in the United States. Adenoregulin works on the human body through the adenosine receptors, a fundamental component throughout all human cellular fuel. These receptors may offer a target for the treatment of depression, stroke and cognitive loss diseases, such as Alzheimer’s disease and also Parkinson’s.

Antimicrobial peptides: Dermaseptins, including adenoregulins (with 33 amino acids), plasticins and philloseptins form part of a family of a broad spectrum of antimicrobial peptides involved in the defence of frogs’ bare skin against microbial invasion. These are the first vertebrate peptides that show lethal effects against filamentous fungi responsible for severe opportunistic infections which accompany the immunodeficiency syndrome and the use of immunosuppressive agents. They also show lethal effects against a broad spectrum of bacteria both large+ and large-, fungi, yeasts and protozoa. Several years of research carried out at the University of Paris have shown that peptides Dermaseptin B2 and B3 are effective in killing certain types of cancer cells. Research at Queens University in Belfast recently won a prestigious award for his ground-breaking work with cancer and Kambô. Its action mechanism is produced by inhibiting the angiogenesis of tumour cells, with selective cytotoxicity for these cells.

Bradykinins – such as phyllokinins and tryptophilins. They are peptides with structure and properties similar to human bradykinin. They are important sources of scientific study as they are hypotensive and due to producing vasodilation, contraction of the non-vascular smooth muscle, increase vascular permeability, also related to the mechanism of inflammatory pain.

Bombesins – these peptides stimulate the secretion of hydrochloric acid by acting on the G cells of the stomach, regardless of the pH of the medium. They also increase pancreatic secretion, intestinal myoelectric activity and smooth muscle contractibility.


"Amphibian skin has long been favored in folklore for its medicinal properties," said Louise A. Rollins-Smith, Ph.D., associate professor of Microbiology & Immunology and principal investigator at Vanderbilt University Medical Center. "Frogs are a rich source of potentially useful molecules that might work against human pathogens."


References:

Peter Gorman, ‘Making magic’ from Omni, July 1993
Marcelo Bolshow Gomes, ‘Kambô The Spirit of the Shaman’
‘Ruolo dei peptidi antimicrobici nell’ immmunita’ innata’, Universita’ di Roma.

 Articles and essays

Gio L., Research and Treatments
S. A. (1984) Ph.D. dissertation (Columbia University, New York).
V. Erspamer, G. F. & Cei, J. M. (1986) Comp. Biochem. Physiol. C 85, 125-137.

‘Sostanze bioattive: dalla pelle di un anfibio al cervello umano’, Academy of Science, University of Rome, Sapienza, 1987